James D Finklea
Overview
Explore the profile of James D Finklea including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
107
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Koenig C, Monogue M, Shields R, Sakon C, Fratoni A, Roenfanz H, et al.
Antimicrob Agents Chemother
. 2024 Dec;
69(1):e0153924.
PMID: 39655913
Persons with CF (pwCF) present altered pharmacokinetics (PK) and are often infected with multidrug-resistant (MDR) bacteria. Herein, we describe the PK of cefiderocol, a siderophore cephalosporin with potent activity against...
2.
Ratti G, Smith H, Mirfakhraee S, Reisch J, Cohen L, Jain R, et al.
J Cyst Fibros
. 2024 Oct;
24(1):47-52.
PMID: 39419654
Background: The constellation of hypertension, truncal obesity, impaired fasting glucose, low high-density lipoprotein, and hypertriglyceridemia is known as metabolic syndrome (MetSyn) and is associated with cardiovascular and other diseases. Elexacaftor-tezacaftor-ivacaftor...
3.
Gross J, Finklea J, Caceres S, Poch K, Hasan N, Jia F, et al.
ERJ Open Res
. 2024 Jul;
10(4).
PMID: 38978544
Rationale: Nontuberculous mycobacteria (NTM) has been reported to be transmitted between people with cystic fibrosis (CF) attending CF centres. A suspected outbreak was investigated at the University of Texas Southwestern...
4.
Wang A, Lee M, Keller A, Jian S, Lowe K, Finklea J, et al.
J Cyst Fibros
. 2023 May;
23(1):91-98.
PMID: 37244841
Background: There is a well described sex-disparity in outcomes of individuals with cystic fibrosis (CF), with females faring worse than males. Given the dramatic improvement in overall health of people...
5.
Esquivel M, Monogue M, Smith G, Finklea J, Sanders J
J Glob Antimicrob Resist
. 2021 Dec;
28:67-70.
PMID: 34936925
Objectives: Vancomycin remains a first-line treatment for methicillin-resistant Staphylococcus aureus (MRSA)-mediated acute pulmonary exacerbations (APEs) in adult cystic fibrosis (CF) patients; however, optimal alternatives remain poorly defined. The aim of...
6.
Nolan P, Jain R, Cohen L, Finklea J, Smith T
Diagn Microbiol Infect Dis
. 2020 Nov;
99(2):115204.
PMID: 33152675
Pseudomonas aeruginosa is a commonly isolated pathogen in adults with cystic fibrosis (CF). Antimicrobial resistance is an escalating problem due to chronic colonization and frequent antimicrobial exposure. Ceftolozane-tazobactam (C/T) and...
7.
End-of-Life Care in Cystic Fibrosis: Comparing Provider Practices Based on Lung Transplant Candidacy
Lange A, Rueschhoff A, Terauchi S, Cohen L, Reisch J, Jain R, et al.
J Palliat Med
. 2020 May;
23(12):1606-1612.
PMID: 32380886
The optimal timing to introduce palliative care (PC) and end-of-life (EOL) conversations into the lives of people with cystic fibrosis (CF) has not been established. Compare EOL care practices for...
8.
Atkin S, Abid S, Foster M, Bose M, Keller A, Hollaway R, et al.
Infect Drug Resist
. 2018 Oct;
11:1499-1510.
PMID: 30271183
Purpose: Ceftazidime-avibactam is a novel antimicrobial combining a third-generation cephalosporin with a non-β-lactam β-lactamase inhibitor that was recently approved to treat Gram-negative hospital- and ventilator-acquired pneumonia. The use of ceftazidime-avibactam...
9.
Finklea J, Hollaway R, Lowe K, Lee F, Le J, Jain R
Diagn Microbiol Infect Dis
. 2018 Jun;
92(1):75-77.
PMID: 29884565
Ceftolozane/tazobactam is a combination intravenous antibiotic with potentially important activity against drug-resistant Gram-negative organisms. Ceftolozane/tazobactam's in vitro activity was evaluated in 30 samples collected from 23 adult cystic fibrosis patients...
10.
Evaluating Simulation-Based ACLS Education on Patient Outcomes: A Randomized, Controlled Pilot Study
Han J, Trammell A, Finklea J, Udoji T, Dressler D, Honig E, et al.
J Grad Med Educ
. 2014 Sep;
6(3):501-6.
PMID: 25210581
Background: Simulation training is widely accepted as an effective teaching tool, especially for dealing with high-risk situations. Objective: We assessed whether standardized, simulation-based advanced cardiac life support (ACLS) training improved...